U.S. Office REITs Stock News

In 2025, Twist Bioscience’s CEO and Chair Emily M. Leproust received total compensation of US$13,781,570, while recent insider activity showed only stock sales and no purchases alongside adjustments in institutional holdings. At the same time, multiple brokerage firms reiterated positive views on Twist Bioscience’s semiconductor-based DNA synthesis platform, collectively maintaining an “Outperform” stance backed by confidence in its synthetic biology technology. Building on this renewed...

Capricor Therapeutics recently reported that its Phase 3 trial of deramiocel met both primary and secondary endpoints and entered commercialization and distribution agreements with Nippon Shinyaku covering the U.S., Japan, and Europe, with potential milestones totalling US$1.50 billion. This combination of late-stage clinical success and a broad global partnership materially advances Capricor’s path from a purely clinical-stage company toward potential commercial execution. We’ll now examine...

If you are wondering whether Wendy's current share price reflects good value or lingering concerns, this breakdown is designed to help you connect the dots before you make your own call. The stock closed at US$8.65, with returns of 5.9% over the past week and 5.7% over the past month, while the 1 year return of a 38.6% decline and 3 year and 5 year returns of 55.9% and 50.8% declines tell a different story about longer term sentiment. Recent headlines around Wendy's have focused on how the...

Recently, APA Corporation drew attention as investors reacted to growing liquefied natural gas demand, seasonal cooling trends, and the company’s diversified operations across the US, Egypt, the North Sea, and Suriname. The interest also reflects APA’s focus on cost-saving measures and disciplined spending, which are seen as enhancing its operational flexibility amid shifting energy demand patterns. We’ll now examine how APA’s emphasis on LNG-linked growth and cost discipline could influence...

Earlier this week, Piper Sandler downgraded Wolverine World Wide’s rating after the company issued full-year adjusted earnings guidance that came in below analyst expectations, despite previously reporting a quarter that exceeded profit and revenue forecasts. This contrast between stronger recent performance and more cautious guidance has drawn attention to how much weight investors now place on Wolverine’s forward outlook rather than its latest results. We’ll now examine how Wolverine’s...

If you are wondering whether Coherent's current share price lines up with its underlying worth, you are not alone. That is exactly what this article will unpack. The stock last closed at US$178.06, with a 7 day return of 8.4% decline, a 30 day return of 9.8% decline, a year to date return of 8.4% decline, and a 1 year return of 98.1% that sits alongside a 3 year return of 331.6% and a 5 year return of 101.7%. Those moves have come as Coherent continues to attract attention in the broader...

Recent commentary around Hilton Grand Vacations (HGV) has focused on two pressure points for investors: weaker tour volumes over the past two years and capital spending that appears to be eroding already modest returns on capital. See our latest analysis for Hilton Grand Vacations. Against the backdrop of softer tour activity and questions around capital efficiency, Hilton Grand Vacations’ share price has moved to $48.17, with a 30 day share price return of 12.02% and a 1 year total...

Some investors may be wondering if Capital Southwest at around US$22.98 is still offering good value, or if most of the upside has already been priced in. The stock shows returns of 3.1% over the past week, 2.6% over the last 30 days, 3.1% year to date, 18.6% over 1 year, 76.2% over 3 years and 118.2% over 5 years. This raises questions about how current expectations line up with its fundamentals. Recent coverage has focused on Capital Southwest's position in the diversified financials space...

In early January 2026, Ocean Power Technologies, Inc. announced a contract worth more than US$5,000,000 to deploy four MERROWS-equipped PowerBuoy systems in support of a U.S. Coast Guard homeland security mission off the coast of San Diego. The project will link buoy-based sensors with Anduril surveillance towers into the Department of Homeland Security’s chosen C5I environment, using Anduril’s Lattice platform to deliver unified maritime domain awareness and real-time decision...

Investors may be considering whether Restaurant Brands International is priced fairly at its current level, or if the share price leaves some value on the table for long term holders. The stock most recently closed at US$69.00, with returns of 1.8% over the past week, a 2.5% decline over the past month, and gains of 1.8% year to date, 17.6% over 1 year, 15.0% over 3 years, and 30.4% over 5 years. Recent headlines around Restaurant Brands International have focused on the broader fast food...

In early January 2026, reports surfaced that OpenAI was exploring a potential takeover of Pinterest, aiming to combine ChatGPT’s capabilities with Pinterest’s billions of intent-rich images, ad infrastructure, and commerce features to build a more integrated AI-powered discovery and shopping ecosystem. At the same time, Pinterest has been rolling out its own AI tools, a curated Pinterest Assistant, and creator-led shoppable content partnerships, underscoring how it is positioning itself as a...

In recent days, Universal Health Services has come under pressure after Wells Fargo downgraded the hospital operator and Bank of America voiced concerns about the broader hospital sector outlook, while TD Cowen and other brokers reiterated generally positive ratings. This mix of caution and optimism highlights a growing debate over how fading post‑pandemic benefits and rising legislative risks could reshape hospitals’ operating landscape. Next, we will examine how this more cautious view on...

Progyny (PGNY) is back in focus after a recent Keybanc upgrade, with the firm citing continued confidence in the fertility benefits provider, as solid year over year revenue and profit gains support investor interest. See our latest analysis for Progyny. The recent Keybanc upgrade and 52 week high come on top of a 90 day share price return of 34.28% and a 1 year total shareholder return of 43.87%, although the 3 and 5 year total shareholder returns remain negative. This suggests momentum has...

President Trump’s proposal to ban institutional investors from buying single-family homes has put American Homes 4 Rent (AMH) in the spotlight, as investors reassess regulatory risk around its single-family rental focused business model. See our latest analysis for American Homes 4 Rent. The regulatory headlines have arrived after a tougher stretch for the stock, with a 1 day share price return of a 1.93% decline and a 1 year total shareholder return of an 8.9% decline. This suggests momentum...

Monolithic Power Systems (MPWR) is back on investors’ radar after a 4.4% share move, which came alongside a broader semiconductor rally linked to artificial intelligence enthusiasm at CES and changing expectations for Federal Reserve policy. See our latest analysis for Monolithic Power Systems. That 4.4% jump sits within a mixed but generally positive trend, with a 7 day share price return of 2.42%, a 90 day share price return of 6.03% and a 1 year total shareholder return of 63.55%. This...

If you are wondering whether Main Street Capital is priced attractively right now, this article walks through its value case in a clear and practical way. The stock last closed at US$61.19, with a 1 year return of 13.9%, a 3 year return of 103.0% and a 5 year return of 177.4%. Shorter term moves include a 0.9% decline over the past week and a 2.8% decline over the past month. Recent attention on Main Street Capital has largely centered on its position as a listed business development company...

Howmet Aerospace (HWM) has caught investor attention recently, with the stock’s monthly return of 13.5% and past 3 months return of 18.6% inviting closer inspection of what might be driving sentiment. See our latest analysis for Howmet Aerospace. That recent momentum sits on top of a longer run where the share price return has been strong, with a 1 year total shareholder return of 94.29% and a very large 5 year total shareholder return. This suggests sentiment has shifted materially as...

In recent days, analysis of United Community Banks, Inc. highlighted that the regional lender has delivered only 4.1% annual revenue growth and 6.2% annual earnings per share growth over the past two years, lagging many banking peers. Forecasts pointing to relatively modest tangible book value per share growth and slower capital generation have raised questions about how effectively the bank is turning its expansion across the Southeast into shareholder value. Now we’ll examine how...

F5 (FFIV) is under close watch after disclosing a sophisticated nation state cyberattack that hit its BIG-IP product development environment, prompted revenue forecast revisions, and triggered multiple securities class action lawsuits questioning earlier disclosures. See our latest analysis for F5. F5's US$269.31 share price has seen a 4.94% 7 day share price return and a 4.35% 30 day share price return, while the 1 year total shareholder return of 5.89% contrasts with a much stronger 3 year...

SmartStop Self Storage REIT (SMA) has been drawing attention after recent trading, with the stock last closing at $32.22. Short term returns are mixed, which has some investors revisiting fundamentals and valuation. See our latest analysis for SmartStop Self Storage REIT. That recent 1-day share price return of 1.77% and 7-day share price return of 4.75% sit against a year to date share price return of 4.75%, while the 90-day share price return of 7.71% indicates that momentum has been fading...

In early January 2026, Harmony Biosciences Holdings drew renewed attention as it advanced clinical programs for WAKIX and other rare neurological disease candidates while preparing for a company presentation at the J.P. Morgan Healthcare Conference. This combination of an expanding pipeline, solid reported profitability, and predominantly positive analyst sentiment has sharpened investor focus on the company’s long-term prospects. Now we’ll examine how Harmony’s progress with WAKIX and its...

If you are wondering whether Chubb's current share price lines up with its underlying value, you are not alone, and that is exactly what this article will help you unpack. Chubb shares last closed at US$306.81, with returns of a 1% decline over the past week, 3.5% over the past month, a 1% decline year to date, 20.6% over the past year, 41% over three years, and 113.6% over five years, which can influence how investors think about both growth potential and risk today. Recent headlines around...

Mirum Pharmaceuticals (MIRM) has drawn attention after initiating the BLOOM Phase 2 trial of MRM-3379 in Fragile X syndrome, alongside fresh institutional interest and recent revenue growth that some investors interpret as a sign of business momentum. See our latest analysis for Mirum Pharmaceuticals. The recent 6.09% 1 day share price return and 33.86% 30 day share price return, taking Mirum to $86.57, line up with the Phase 2 trial news, institutional buying and revenue growth. At the same...

In early January 2026, Raymond James downgraded MPLX from Outperform to Market Perform, following JP Morgan’s earlier move to lower its rating as analysts flagged limited organic growth prospects and a heavier reliance on mergers and acquisitions. At the same time, MPLX reported higher quarterly revenue and net profit than a year earlier and scheduled a February 3, 2026 earnings call, setting up a contrast between improving recent results and more cautious views on its longer-term growth...